While COVID-19 was not specifically mentioned in later crawls, “calcitonin” and “gene-related” did appear in blogs, indicative of migraine stakeholder concerns about the FDA approval of an entirely new class of medications to treat migraines (see Appendices E and F in S1 File) [17]. The gene discussed is CALCA; the disease is migraine disorder.